Literature DB >> 31396638

Obesity and its long-term impact on sacrocolpopexy key outcomes (OBELISK).

Martin Smazinka1, Vladimir Kalis1,2, Martin Havir1, Linda Havelkova3, Khaled M Ismail4,5, Zdenek Rusavy1,2.   

Abstract

INTRODUCTION AND HYPOTHESIS: Sacrocolpopexy is the preferred contemporary approach to managing significant apical pelvic organ prolapse. Obesity is an established risk factor for several surgical procedures and can have a negative impact on outcomes. Our goal was to evaluate the impact of BMI on the safety and efficacy of laparoscopic sacrocolpopexy in women with pelvic organ prolapse.
METHODS: A single-center retrospective observational study of women undergoing laparoscopic sacrocolpopexy between January 1, 2015, and December 31, 2017.
RESULTS: We found 299 procedures: 82 (27.4%), 147 (49.2%) and 70 (23.4%) in women with BMI <25 (normal weight), BMI ≥ 25 - < 30 (overweight) and BMI ≥ 30 (obese), respectively. Perioperative and early postoperative complications were generally low and not statistically significantly different between the groups. At 12 months postoperatively, 81 (98.8%), 136 (92.5%) and 62 (88.6%) normal-weight, overweight and obese women attended their follow-up, respectively. All obese women attending the follow-up scored an overall Patient Global Impression of Improvement (PGI-I) of ≤ 3. The Pelvic Floor Distress Inventory (PFDI) scores showed a significant improvement in all domains and were similar between the study groups. In total, there was one (0.4%) anatomical apical compartment failure, three (1.1%) anterior compartment failures and two (0.7%) posterior compartment failures with no significant differences between the groups. Similarly, there were no differences in functional outcomes or mesh position as assessed by ultrasound.
CONCLUSIONS: There were no differences in surgical, short- and long-term outcomes of laparoscopic sacrocolpopexy for pelvic organ prolapse in obese compared with non-obese women.

Entities:  

Keywords:  BMI; Laparoscopy; POP; Prolapse; Sacrocolpopexy; Urogynecology

Mesh:

Year:  2019        PMID: 31396638     DOI: 10.1007/s00192-019-04076-8

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  21 in total

1.  Association Between Obesity and Perioperative Morbidity in Open Versus Laparoscopic Sacrocolpopexy.

Authors:  Gabriela E Halder; Jason L Salemi; Stuart Hart; Emad Mikhail
Journal:  Female Pelvic Med Reconstr Surg       Date:  2017 Mar/Apr       Impact factor: 2.091

2.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP).

Authors:  Bernard T Haylen; Christopher F Maher; Matthew D Barber; Sérgio Camargo; Vani Dandolu; Alex Digesu; Howard B Goldman; Martin Huser; Alfredo L Milani; Paul A Moran; Gabriel N Schaer; Mariëlla I J Withagen
Journal:  Int Urogynecol J       Date:  2016-04       Impact factor: 2.894

3.  Defecatory dysfunction and fecal incontinence in women with or without posterior vaginal wall prolapse as measured by pelvic organ prolapse quantification (POP-Q).

Authors:  Kathiane Lustosa Augusto; Leonardo Robson Pinheiro Sobreira Bezerra; Sthela Maria Murad-Regadas; José Ananias Vasconcelos Neto; Camila Teixeira Moreira Vasconcelos; Sara Arcanjo Lino Karbage; Andreisa Paiva Monteiro Bilhar; Francisco Sérgio Pinheiro Regadas
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2017-04-26       Impact factor: 2.435

4.  Pelvic floor symptoms and severity of pelvic organ prolapse in women seeking care for pelvic floor problems.

Authors:  Montserrat Espuña-Pons; Manuel Fillol; María A Pascual; Pablo Rebollo; Ana M Mora
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2014-04-13       Impact factor: 2.435

5.  Quality of life and sexual functıon in obese women with pelvic floor dysfunction.

Authors:  Dilek Bilgic; Sule Gokyildiz; Nezihe Kizilkaya Beji; Onay Yalcin; Funda Gungor Ugurlucan
Journal:  Women Health       Date:  2018-09-24

6.  The standardization of terminology for researchers in female pelvic floor disorders.

Authors:  A M Weber; P Abrams; L Brubaker; G Cundiff; G Davis; R R Dmochowski; J Fischer; T Hull; I Nygaard; A C Weidner
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

Review 7.  Obesity and pelvic organ prolapse: a systematic review and meta-analysis of observational studies.

Authors:  Ayush Giri; Katherine E Hartmann; Jacklyn N Hellwege; Digna R Velez Edwards; Todd L Edwards
Journal:  Am J Obstet Gynecol       Date:  2017-02-07       Impact factor: 8.661

8.  Sexual function is related to body image perception in women with pelvic organ prolapse.

Authors:  Lior Lowenstein; Tondalaya Gamble; Tatiana V Deniseiko Sanses; Heather van Raalte; Cassandra Carberry; Sharon Jakus; Scott Kambiss; Sarah McAchran; Thythy Pham; Sarit Aschkenazi; Kay Hoskey; Kimberly Kenton
Journal:  J Sex Med       Date:  2009-06-02       Impact factor: 3.802

Review 9.  Epidemiology and outcome assessment of pelvic organ prolapse.

Authors:  Matthew D Barber; Christopher Maher
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894

10.  How does site of pelvic organ prolapse repair affect overactive bladder symptoms?

Authors:  Alexis A Dieter; Autumn L Edenfield; Alison C Weidner; Nazema Y Siddiqui
Journal:  Female Pelvic Med Reconstr Surg       Date:  2014 Jul-Aug       Impact factor: 2.091

View more
  3 in total

1.  Effect of BMI on clinical outcomes following minimally invasive sacrocolpopexy.

Authors:  Radhika Patnam; Katherine Husk; Abhishek Sripad; Kathryn Barletta; Alexis Dieter; Elizabeth J Geller
Journal:  J Robot Surg       Date:  2020-04-16

2.  Pelvic organ prolapse and uterine preservation: a cohort study (POP-UP study).

Authors:  Daniel Gagyor; Vladimir Kalis; Martin Smazinka; Zdenek Rusavy; Radovan Pilka; Khaled M Ismail
Journal:  BMC Womens Health       Date:  2021-02-17       Impact factor: 2.809

3.  Pelvic organ prolapse and uterine preservation: a survey of female gynecologists (POP-UP survey).

Authors:  Peter Urdzík; Vladimir Kalis; Mija Blaganje; Zdenek Rusavy; Martin Smazinka; Martin Havir; Rastislav Dudič; Khaled M Ismail
Journal:  BMC Womens Health       Date:  2020-10-27       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.